Prelude Therapeutics Statistics

Total Valuation

PRLD has a market cap or net worth of $439.92 million. The enterprise value is $352.98 million.

Market Cap	439.92M
Enterprise Value	352.98M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

PRLD has 100.55 million shares outstanding. The number of shares has increased by 1.52% in one year.

Current Share Class	66.29M
Shares Outstanding	100.55M
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	+4.70%
Owned by Insiders (%)	4.48%
Owned by Institutions (%)	7.99%
Float	35.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.11
Forward PS	n/a
PB Ratio	5.43
P/TBV Ratio	6.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	29.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.26.

Current Ratio	1.99
Quick Ratio	1.95
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.45% and return on invested capital (ROIC) is -54.72%.

Return on Equity (ROE)	-99.45%
Return on Assets (ROA)	-40.74%
Return on Invested Capital (ROIC)	-54.72%
Return on Capital Employed (ROCE)	-116.92%
Weighted Average Cost of Capital (WACC)	7.87%
Revenue Per Employee	$153,671
Profits Per Employee	-$1.26M
Employee Count	79
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +383.96% in the last 52 weeks. The beta is 0.72, so PRLD's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+383.96%
50-Day Moving Average	3.52
200-Day Moving Average	2.04
Relative Strength Index (RSI)	54.33
Average Volume (20 Days)	452,660

Short Selling Information

The latest short interest is 1.81 million, so 1.80% of the outstanding shares have been sold short.

Short Interest	1.81M
Short Previous Month	2.32M
Short % of Shares Out	1.80%
Short % of Float	5.10%
Short Ratio (days to cover)	7.16

Income Statement

In the last 12 months, PRLD had revenue of $12.14 million and -$99.50 million in losses. Loss per share was -$1.29.

Revenue	12.14M
Gross Profit	12.14M
Operating Income	-103.27M
Pretax Income	-99.50M
Net Income	-99.50M
EBITDA	-101.56M
EBIT	-103.27M
Loss Per Share	-$1.29

Full Income Statement

Balance Sheet

The company has $103.21 million in cash and $17.79 million in debt, giving a net cash position of $85.43 million or $0.85 per share.

Cash & Cash Equivalents	103.21M
Total Debt	17.79M
Net Cash	85.43M
Net Cash Per Share	$0.85
Equity (Book Value)	68.64M
Book Value Per Share	0.83
Working Capital	52.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.30 million and capital expenditures -$67,000, giving a free cash flow of -$56.37 million.

Operating Cash Flow	-56.30M
Capital Expenditures	-67,000
Depreciation & Amortization	1.71M
Net Borrowing	-208,000
Free Cash Flow	-56.37M
FCF Per Share	-$0.56

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-850.63%
Pretax Margin	-819.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PRLD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.52%
Shareholder Yield	-1.52%
Earnings Yield	-22.70%
FCF Yield	-12.86%

Analyst Forecast

The average price target for PRLD is $5.67, which is 29.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.67
Price Target Difference	29.60%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PRLD has an Altman Z-Score of -7.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.92
Piotroski F-Score	2